Mylan Inc., of Pittsburgh, confirmed that federal district court granted its request to enforce a settlement agreement between Endo Pharmaceuticals Inc., of Malvern, Pa., and Mylan settling patent litigation in connection with Mylan's filing of an abbreviated new drug application for a generic version of Frova (frovatriptan succinate) for use in acute migraine.